• OPEN AN ACCOUNT
Indian Indices
Nifty
18,337.20 29.10
(0.16%)
Sensex
61,421.83 112.92
( 0.18%)
Bank Nifty
38,337.40 121.25
( 0.32%)
Nifty IT
38,830.15 25.20
( 0.06%)
Global Indices
Nasdaq
14,893.75 86.94
(0.59%)
Dow Jones
35,911.81 -201.81
(-0.56%)
Hang Seng
24,218.03 -165.29
(-0.68%)
Nikkei 225
28,333.52 209.24
(0.74%)
Forex
USD-INR
74.15 0.16
(0.22%)
EUR-INR
84.61 -0.06
(-0.07%)
GBP-INR
101.30 -0.09
(-0.09%)
JPY-INR
0.65 0.00
(-0.31%)

EQUITY - MARKET SCREENER

Vaxtex Cotfab Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
535352
INE098201010
8.8389402
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VCL
472.22
85.33
EPS(TTM)
Face Value()
Div & Yield %
0.18
10
0
 

As on: Jan 18, 2022 09:35 AM

To,

The Members,

Your Directors present the 15thAnnual Report on the Business and Operations of the Company along with the Audited Statement of Accounts for the Financial Year ended on 31stMarch, 2020.

1. FINANCIALRESULT

The financial performance of the Company for the Financial Year ended on 31st March, 2020 and for the previous Financial Year ended on 31st March, 2019 is given below:

(Rs. In Lakhs)

Particulars 2019-20 2018-19
Revenue from Operations 2,775.80 2,197.27
Other Income 1.77 4.53
Total Income 2,777.57 2,201.80
Total Expenses 2,758.84 2,114.07
Profit Before Tax 18.73 87.73
Tax Expense: Current Tax 4.87 24.03
Deferred Tax 4.54 3.50
T otal T ax expense 9 28
Profit for the Period 9.32 60.20
Earnings Per Share (EPS)
Basic 0.15 14.96
Diluted 0.15 14.96

2. OPERATIONS

On Standalone basis, revenue from operations for Financial Year 2019-20 was Rs. 2775.80Crores. The Profit before tax of the Company for the Financial Year 2019-20 stood at Rs. 18.73Crores making Net Profit after Tax for the Financial Year2019-20 of Rs. 9.32 Crores.

3. CHANGE IN NATURE OF BUSINESS, IFANY

During the Financial Year 2019-20, Our Company got listed on SME Platform of NSE Limited. Further Directors in the Board Meeting held on 30th July, 2020 have started two different units in the name of:

• Vaxlife - for trading of garments and fabrics

• Vax Pharma - for manufacturing / trading of marks and PPE kits.

4. ANNUAL RETURN

The extract of the Annual Return pursuant to the provisions of Section 92 of the Companies Act, 2013 read with Rule 12 of the Companies (Management and Administration) Rules, 2014 in Form No. MGT - 9 is enclosed herewith as Annexure 1and also it is available on the Company's website under Section Investors.

5. BOARD MEETINGS AND ATTENDANCE

The Directors of the Company met at regular intervals at least once in a quarter with the gap between two meetings not exceeding 120 days to take a view of the Company's policies and strategies apart from the Board Matters.

During the year under the review, the Board of Directors met 5 (five) times viz 30th May, 2019, 28th August, 2019, 15th November, 2019, 2nd January, 2020, 16th March, 2020.

6. DIRECTORS RESPONSIBILITY STATEMENT

In accordance with the provisions of Section 134 (3)(c) and Section 134(5) of the Companies Act, 2013, to the best of their knowledge and belief the Board of Directors hereby submit that:

a. In the preparation of the Annual Accounts, for the year ended on March 31, 2020 the applicable accounting standards have been followed and there are no material departure from thesame,

b. The directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the company at the end of financial year and of the profit of the company for the financial year ended on March 31,2020.

c. The directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of Companies Act, 2013 for safeguarding the assets of the company and for preventing and detecting fraud and otherirregularities,

d. The directors had prepared the Annual Accounts on a going concernbasis,

e. The directors had laid down internal financial controls to be followed by the Company and that such internal financial controls are adequate and are operating effectivelyand

f. The Directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operatingeffectively.

7. COMMENT ON AUDITORS'REPORT

There were no qualifications, reservations, adverse remarks or disclaimer made by the Auditors in their report on the financial statement of the Company for the financial year ended on March 31, 2020. Furthermore, there were no frauds reported by the Auditors of the Company pursuant to Companies Act, 2013 and the rules made there- under. Maintenance of cost records as specified under Companies Act, 2013 is not applicable to theCompany.

8. PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS MADE UNDER SECTION 186 OF THE COMPANIES ACT,2013

The details of loans, investment, guarantees and securities covered under the provisions of section 186 of the Companies Act, 2013 are provided in the financial statement.

9. PARTICULARS OF CONTRACTS OR ARRANGEMENTS MADE WITH RELATED PARTIES

All transactions to be entered by the Company with related parties will be in the ordinary course of business and on an arm's length basis. However, the Company has not entered into any related party transaction, as provided in Section 188 of the Companies Act, 2013, with the related party. Hence, Disclosure as required under Section 188 of the Companies Act, 2013 is not applicable to the Company.

10. INTERNAL FINANCIAL CONTROL SYSTEMS AND THEIRADEQUACY

The Company has its Internal Financial Control systems commensurate with operations of the Company. The management regularly monitors the safeguarding of its assets, prevention and detection of frauds and errors, and the accuracy and completeness of the accounting records including timely preparation of reliable financialinformation.

The Head of Internal Audit together with External Audit consults and reviews the effectiveness and efficiency of these systems and procedures to ensure that all assets are protected against loss and that the financial and operational information is accurate and complete in allrespects.

11. Reserves &Surplus

Sr. No. Particulars Amount (in Rs.)
1. Reserves and Surplus at the beginning of the year 4,32,58,912
2. Surplus in P & L utilised for Bonus (49,25,000)
3. Securities Premium utilised for Bonus (3,53,25,000)
4. Securities Premium issued 2,23,44,000
5. Current Year's Profit 9,32,055
6. Reserves and Surplus at the end of the year 2,62,84,967

12. DIVIDEND

To conserve resources for future prospect and growth of the Company, your Directors regret to declare any dividend for the Financial Year 2019-20 (Previous year - Nil).

13. MATERIAL CHANGES AND COMMITMENTS, IF ANY, AFFECTING THE FINANCIAL POSITION OF THE COMPANY WHICH HAVE OCCURRED BETWEEN THE END OF THE FINANCIAL YEAR TO WHICH THE FINANCIAL STATEMENTS RELATES AND THE DATE OF THEREPORT

There are no material changes and commitments, affecting the financial position of the Company.

14. TRANSFER TO THE INVESTOR EDUCATION AND PROTECTIONFUND

Pursuant to Section 124 of the Companies Act, 2013, the amount of dividend remaining unpaid or unclaimed for a period of seven years shall be transferred to the Investor Education and Protection Fund ("IEPF"). During the year under review, there was no unpaid or unclaimed dividend in the "Unpaid Dividend Account" lying for a period of seven years from the date of transfer of such unpaid dividend to the said account. Therefore, there were no funds which were required to be transferred to Investor Education and Protection Fund.

15. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE EARNINGS ANDOUTGO

The details of conservation of energy, technology absorption etc. as required to be given under section 134(3)(m) of the Companies Act 2013 read with the Companies (Accounts) Rules, 2014, is not given as the Company has not taken any major step to conserve the energy etc. Further, there was no foreign exchange earnings and outgo during the financial year 2019-20 (Previous Year - Nil).

16. STATEMENT CONCERNING DEVELOPMENT AND IMPLEMENTATION OF THE RISK MANAGEMENT POLICY OF THECOMPANY

The Company has in place, a mechanism to identify, assess, monitor and mitigate various risks towards the key business objectives of the Company. Major risks identified by the business and functions are systematically addressed through mitigating actions on a continuingbasis.

17. DIRECTORS AND KEY MANAGERIALPERSONNEL

The Directors and Key Managerial Personnel of the Company are summarized below:

Sr. No. Name Designation DIN
1. Mr. MithleshkumarM Agrawal Director 03468643
2. Mr. Khushant Gupta1 Managing Director 07958719
3. Mr. Dhaval Patel Independent Director 07770039
4. Ms. Poonam Panchal2 Independent Director 08158195
5. Mr. Aakash Thakor3 Director 08158195
5. Mr. PratapsinghZala Chief Financial Officer -
6. Mr. TejHanj4 Company Secretary -
7. Ms. Priyanka Joshi5 Company Secretary -
8. Mr. Jaimin Gupta Chief Executive Officer -

 

4Mr. Khushant Gupta resigned from the Company w.e.f. 11th September, 2020.

 

2 Ms. Poonam Panchal was appointed as ID and women Director on 2nd April, 2019 and has resigned from the Company w.e.f. 2nd November, 2020.

 

3 Mr. AakashThakor was appointed as Additional Director w.e.f. 12th November, 2020

 

4 Mr TejHanj was appointed as CS on 4th June, 2019 and has resigned from the Company w.e.f. 15th May, 2020

 

5 Ms. Priyanka Joshi was appointed as Company Secretary w.e.f. 7th August, 2020

As per Companies Act, 2013 the Independent Directors are not liable to retire by rotation.

18. DECLARATION BY INDEPENDENTDIRECTORS

Mr. Dhaval Patel, Independent Director of the Company has confirmed to the Board that he meets the criteria of Independence as specified under Section 149 (6) of the Companies Act, 2013 and is qualify to be Independent Director. He also confirmed that he meets the requirements of Independent Director as mentioned under Regulation 16 (1) (b) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The confirmations were noted by the Board.

19. CORPORATEGOVERNANCE

Since the Company has listed its specified securities on the SME Exchange therefore by virtue of Regulation 15 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 the compliance with the corporate governance provisions as specified in regulations 17 to 27 and clauses (b) to (i) of sub-regulation (2) of regulation 46 and para C, D and E of Schedule V are not applicable to the Company. Hence Corporate Governance does not form part of this Board'sReport.

20. DEPOSITS

As per Section 73 of the Companies Act, 2013 the Company has neither accepted nor renewed any deposits during the financial year. Hence the Company has not defaulted in repayment of deposits or payment of interest during the financialyear.

21. FORMAL ANNUAL EVALUATION PROCESS BYBOARD

Pursuant to the provisions of the Companies Act, 2013 and Rules made thereunder, the Board has carried the evaluation of its own performance, performance of Individual Directors, Board Committees, including the Chairman of the Board on the basis of attendance, contribution towards development of the Business and various other criteria as recommended by the Nomination and Remuneration Committee of the Company. The evaluation of the working of the Board, its committees, experience and expertise, performance of specific duties and obligations etc. were carried out. The Directors expressedtheirsatisfactionwiththeevaluationprocessandoutcome.

In a separate meeting of Independent Directors the performances of Executive and NonExecutive Directors were evaluated in terms of their contribution towards the growth and development of the Company. The achievements of the targeted goals and the achievements of the Expansion plans were too observed and evaluated, the outcome of which was satisfactory for all the Directors of theCompany.

22. STATUTORYAUDITOR

M/s. SSRV & Associates, Chartered Accountants, Mumbai, Chartered Accountants, (Firm's Registration No. 135901W), were appointed as the Statutory Auditors of the Company. The Auditor's report for the financial year ended March 31, 2020 has been issued with an unmodified opinion, by the Statutory Auditors.

23. SECRETARIALAUDITOR

The Board appointed Gaurav Bachani& Associates, Company Secretaries, Ahmedabad to conduct Secretarial Audit for the Financial Year 2019-20. The Secretarial Audit Report for the financial year ended 31stMarch, 2020 is annexed herewith marked as Annexure-1 to this Report.

24. DISCLOSURES

A. Composition of AuditCommittee:

Members of the Committee are as follows:

Name Status
Mr. Mithleshkumar M Agrawal Chairman
Mr. Khushant Gupta Member
Mr. Dhavalbhai Patel Member

During the year all the recommendations made by the Audit Committee were accepted by the Board.

B. Composition of Nomination and Remuneration Committee:

Members of the Committee are as follows:

Name Status
Mr. Mithlesh Agrawal Chairman
Ms. Poonam Panchal Member
Mr. Dhavalbhai Patel Member

C. Composition of Stakeholders Relationship Committee: Members of the Committee are as follows:

Name Status
Mr. Mithlesh Agrawal Chairman
Ms. Poonam Panchal Member
Mr. Dhavalbhai Patel Member

25. DISCLOSURES UNDER SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION & REDRESSAL) ACT,2013

The Company has always been committed to provide a safe and conducive work environment to its employees. Your Directors further state that during the year under review there were no cases filed pursuant to the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 as confirmed by the Internal Complaints Committee as constituted by the Company.

26. MANAGEMENT DISCUSSION AND ANALYSIS

Management Discussion and Analysis Report as required under Regulation 34 and Schedule V of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 forms an integral part of this Report, and provides the Company's current working and future outlook as per Annexure-2.

27. ACKNOWLEDGEMENTS

Your Directors would like to express their sincere appreciation for the co-operation and assistance received from the Bankers, Regulatory Bodies, Stakeholders including Financial Institutions, Suppliers, Customers and other business associates who have extended their valuable sustained support and encouragement during the year under review.

Your Directors take this opportunity to recognize and place on record their gratitude and appreciation for the commitment displayed by all executives, officers and staff at all levels of the Company. We look forward for the continued support of every stakeholder in the future.

Registered Office: By the Order of the Board
Survey No. 230, Opp. Mariya Park, VaxtexCotfab Limited
B/h. Ranipur Village, Saijpur - Gopal,
Narol, Ahmedabad - 382 405 Sd/- Sd/-
Aakash Thakor Mithleshkumar Gupta
Place: Ahmedabad Director Director
Date: 8th December, 2020 DIN: 07960192 DIN:03468643